Following 6 cases of dangerous blood clots in women who received the Johnson & Johnson Covid-19 vaccine, the FDA has called for a temporary halt and is convening the Advisory Committee on Immunization Practices (ACIP) to investigate. The agency also is issuing a health warning to women regarding the vaccine. It reads as follows:Original Article
You may also like
The Great RIF(T): One FDA Division’s Destruction and...
More on the Impact of the FDA RIFs: How Information...
Court Rejects Challenge to DEA ALJ Hearing Authority...
Déjà Vu: OPDP Again Targets Provider Branded Website...
ASCA 2024 Performance Update: Can ASCA Improve...
Enforcement Under the New FDA: HPM to Host a Q&A...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.